Ece Kadioglu
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- CAR-T cell therapy research
Papers in ⓘ
-
- Cancer, Hypoxia, and Metabolism 2
-
- Angiogenesis and VEGF in Cancer 2
- Wnt/β-catenin signaling in development and cancer 1
- Fibroblast Growth Factor Research 1
- Co-authors
- Michele De Palma (5 shared papers)Nicolò Rigamonti (2 shared papers)Yvonne Kienast (1 shared paper)Anna Kiialainen (1 shared paper)Chia-Huey Ooi (1 shared paper)Martina Schmittnaegel (1 shared paper)Damya Laoui (1 shared paper)Ioanna Keklikoglou (3 shared papers)
- Journals
- Science Translational Medicine (2 papers)Cell Reports (2 papers)Molecular Cancer Therapeutics (1 paper)Cancers (1 paper)npj Digital Medicine (1 paper)
- Partner nations
- SwitzerlandSpainGermany
In The Last Decade
Ece Kadioglu
8 papers receiving 872 citations
Hit Papers
Peers
Comparison fields: 5 of 63
- Cancer Research 255
- Oncology 462
- Immunology 355
- Molecular Biology 430
- Hepatology 40
Countries citing papers authored by Ece Kadioglu
This map shows the geographic impact of Ece Kadioglu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ece Kadioglu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ece Kadioglu more than expected).
Fields of papers citing papers by Ece Kadioglu
This network shows the impact of papers produced by Ece Kadioglu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ece Kadioglu. The network helps show where Ece Kadioglu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ece Kadioglu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade Hit paper breakdown → | 2017 | 444 |
| 2 | 2014 | 180 | |
| 3 | 2017 | 105 | |
| 4 | 2021 | 61 | |
| 5 | 2021 | 36 | |
| 6 | 2018 | 33 | |
| 7 | 2022 | 19 | |
| 8 | 2023 | 5 |
About Ece Kadioglu
Ece Kadioglu is a scholar working on Cancer Research, Molecular Biology, Oncology, Cardiology and Cardiovascular Medicine and Obstetrics and Gynecology, having authored 8 papers that have together received 883 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (2 papers), Angiogenesis and VEGF in Cancer (2 papers), Endometrial and Cervical Cancer Treatments (2 papers), Peptidase Inhibition and Analysis (2 papers), Cancer Immunotherapy and Biomarkers (1 paper), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), Wnt/β-catenin signaling in development and cancer (1 paper) and Fibroblast Growth Factor Research (1 paper). The work is most often cited by research in Cancer Research (255 citations), Oncology (462 citations), Immunology (355 citations), Molecular Biology (430 citations) and Hepatology (40 citations). Ece Kadioglu has collaborated with scholars based in Switzerland, Spain and Germany. Frequent co-authors include Michele De Palma, Nicolò Rigamonti, Yvonne Kienast, Anna Kiialainen, Chia-Huey Ooi, Martina Schmittnaegel, Damya Laoui, Ioanna Keklikoglou, Ching Ching Leow and Carola H. Ries. Their work appears in journals such as Science Translational Medicine, Cell Reports, Molecular Cancer Therapeutics, Cancers and npj Digital Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.